Sexually transmitted infections and contraceptives: selective issues

Area of Science:

• Reproductive Health
• Infectious Diseases
• Contraception

Background:

• High rates of unintended pregnancy and sexually transmitted infections (STIs) globally necessitate evidence-based interventions.
• Existing contraceptive methods require evaluation for their impact on STI acquisition and reproductive health outcomes.

Purpose of the Study:

• To review current evidence on contraceptive methods, focusing on intrauterine devices (IUDs) and oral contraceptive pills (OCPs).
• To identify gaps in female-controlled dual protection methods and discuss future research directions for managing unintended pregnancies and STIs.

Main Methods:

• Literature review of studies examining contraceptive efficacy and safety.
• Analysis of evidence regarding the relationship between IUDs, OCPs, pelvic inflammatory disease (PID), and STI acquisition.
• Assessment of emerging female-controlled contraceptive technologies.

Main Results:

• Intrauterine devices (IUDs) are a safe contraceptive option, even for women with HIV, with no increased risk of infertility or PID.
• Oral contraceptive pills (OCPs) may be associated with increased risk of chlamydial infections and cervicitis, but not definitively with PID.
• Development of female-controlled methods like FemCap, Reality condoms, microbicides, and spermicides shows promise.

Conclusions:

• IUDs represent a valuable contraceptive choice with a favorable safety profile.
• Further research is crucial to address the need for female-controlled dual protection and to understand interactions between STIs and contraceptives.
• Integrated approaches are necessary to mitigate the public health impact of unintended pregnancies and STIs worldwide.